Skip to search formSkip to main contentSkip to account menu

TNFerade

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
CONTEXT Treatment of pancreatic cancer remains a major oncological challenge and survival is dismal. Most patients, present with… 
2009
2009
4605 Intro: Local control of LAPC with CRT has historically demonstrated survival benefit vs. RT alone. TNF is a nonreplicating… 
2008
2008
6067 Background: The prognosis for patients with locoregionally recurrent HNC remains poor. Re-irradiation with concomitant… 
2007
2007
14585 Background: Rectal cancer presents unique therapeutic considerations due to competing concerns regarding sphincter… 
2005
2005
4097 Background: TNFerade is a replication-deficient adenovector containing the human TNF-α gene regulated by a chemoradiation… 
2004
2004
3038 Background: TNFerade is a replication-deficient adenovector containing the TNF-α gene regulated by a radiation-inducible… 
Review
2004
Review
2004
In this issue of the Journal of Clinical Oncology, Senzer et al [1] describe the results of their phase 1 gene transfer trial of… 
2004
2004
3038 Background: TNFerade is a replication-deficient adenovector containing the TNF-α gene regulated by a radiation-inducible… 
Review
2003
Review
2003
TNFerade is a new gene therapy drug under development by GenVec that employs a replication-deficient adenovector carrying the…